Oxford Medical Simulation, a provider of immersive clinical simulation for healthcare and academic institutions, has secured £5 million in growth financing from Salica Investments. The funding will support the next stage of development for the London-based business as it expands its presence across health systems and universities.
The platform enables clinicians and healthcare students to practise clinical scenarios in realistic digital environments. Hospitals, health systems and universities across the United States, the United Kingdom and internationally use the software to deliver repeatable training and track progress through learning analytics, helping institutions improve clinical readiness and support workforce development.
The financing will enable Oxford Medical Simulation to further scale its presence in US health systems and academic institutions. It will also support product innovation including new simulation scenarios, learning analytics and workflow tools, while expanding the infrastructure required to deliver clinical training through its platform.
This financing allows us to invest confidently in the next phase of OMS. Our partners in US healthcare and academia are focused on outcomes – safer practice, better-prepared staff and more efficient delivery. This growth capital from Salica means we can move faster on exactly those priorities: expanding our breadth and depth of content, deepening our analytics capabilities, and supporting more institutions to transform their training for the new generation of learners.
Oxford Medical Simulation is exactly the type of business we look to support. The team has built a differentiated platform, proven at scale, and is working with leading health systems and universities to address a critical need: giving clinicians and students the chance to practise safely. We are delighted to back OMS as they scale their impact across healthcare and education.
